Back
Design Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
52
DSGN
Design Therapeutics, Inc.
Last Price:
$9.62
Seasonality Move:
-15.75%
7 Day Trial
ALL ACCESS PASS
$
7
Design Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Design Therapeutics, Inc. has on average historically risen by 28.1% based on the past 4 years of stock performance.
-
Design Therapeutics, Inc. has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Design Therapeutics, Inc. Stock Undervalued?The current Design Therapeutics, Inc. [DSGN] share price is $9.63. The Score for DSGN is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
DSGN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Design Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Design Therapeutics, Inc. has on average historically risen by 28.1% based on the past 4 years of stock performance.
Design Therapeutics, Inc. Stock Rating
Buy
52
Design Therapeutics, Inc. (DSGN)
is a Buy
Is Design Therapeutics, Inc. overpriced?
-
Design Therapeutics, Inc. has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Design Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
designtx.com
52-Week Data
52-Week High:
10.31
52-Week Low:
2.60
Prediction Charts
Market Cap:
548.6M
Price in USD:
9.63
Volume:
111.5K
Beta:
1.65
Technical Analysis
SMA50:
7.94
SMA100:
6.88
SMA200:
5.40
52-Wk Change:
48.38%
Stock Predictions
-
Is Design Therapeutics, Inc. stock public?Yes, Design Therapeutics, Inc. is a publicly traded company.
-
What is the Design Therapeutics, Inc. stock quote today?The Design Therapeutics, Inc. stock price is 9.63 USD today.
-
How to buy Design Therapeutics, Inc. stock online?You can buy Design Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-5 | 9.89 | 9.77 | 10.31 | 9.69 |
| Dec-8 | 9.62 | 9.86 | 10.18 | 9.38 |
| Dec-9 | 9.81 | 9.27 | 10.07 | 9.12 |
| Dec-10 | 9.20 | 9.42 | 9.53 | 9.00 |
| Dec-11 | 9.46 | 9.24 | 9.67 | 9.16 |
| Dec-12 | 9.30 | 9.43 | 9.56 | 9.23 |
| Dec-15 | 9.53 | 9.12 | 9.56 | 9.08 |
| Dec-16 | 9.09 | 9.62 | 9.63 | 9.08 |
| Dec-17 | 9.65 | 8.86 | 9.68 | 8.69 |
| Dec-18 | 8.93 | 9.01 | 9.44 | 8.80 |
| Dec-19 | 8.92 | 9.68 | 9.83 | 8.43 |
| Dec-22 | 9.73 | 9.96 | 10.11 | 9.65 |
| Dec-24 | 9.72 | 9.74 | 10.08 | 9.69 |
| Dec-26 | 9.77 | 9.63 | 9.77 | 9.46 |
Design Therapeutics, Inc. Earnings
Design Therapeutics, Inc. Earnings Report: Per Share Design Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Design Therapeutics, Inc. Forecast Revenue Growth
Design Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Design Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.38 per share, and a decrease next year of $0.04 per share.
* Design Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.